RecruitingPhase not listedNCT04706663
Precision-Based Genomics in Prostate Cancer
Sponsor: National Cancer Institute (NCI)
New York, NY · +8 more sites
Prostate Cancer clinical trials in New York, NY
73 recruiting prostate cancer studies with a site in New York, NY.
RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
New York, NY · +20 more sites
RecruitingPhase 1NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: AstraZeneca
New York, NY · +11 more sites
RecruitingPhase 3NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Sponsor: Pfizer
Commack, NY · Harrison, NY · Lake Success, NY · +124 more sites
RecruitingPhase 1 / Phase 2NCT07590934
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
New York, NY · +11 more sites
RecruitingNot applicableNCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Sponsor: Axonics, Inc.
New York, NY · +22 more sites
RecruitingPhase 1 / Phase 2NCT07871435
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
Sponsor: GI Innovation, Inc.
New York, NY
RecruitingPhase not listedNCT07690917
A Study of a New PET Scanner in People With Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +4 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
New York, NY · +30 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
New York, NY · +14 more sites
RecruitingNot applicableNCT06037954
A Study of Mental Health Care in People With Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 3NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Sponsor: Alliance for Clinical Trials in Oncology
Buffalo, NY · Commack, NY · Harrison, NY · +135 more sites
RecruitingPhase 2NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Daiichi Sankyo
Buffalo, NY · New York, NY · +11 more sites
RecruitingPhase 1NCT06095089
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Sponsor: Janssen Research & Development, LLC
New York, NY · +11 more sites
RecruitingPhase 1NCT05818683
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Brooklyn, NY · Mineola, NY · New York, NY · +4 more sites
RecruitingPhase 1NCT07082920
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Sponsor: Janssen Research & Development, LLC
New York, NY · +3 more sites
RecruitingPhase 1 / Phase 2NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Buffalo, NY · New York, NY · +9 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Mineola, NY · New York, NY · The Bronx, NY · +56 more sites
RecruitingPhase 1NCT07319871
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Sponsor: Janssen Research & Development, LLC
New York, NY · +2 more sites
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
New York, NY · Syracuse, NY · The Bronx, NY · +32 more sites
RecruitingPhase 3NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
East Syracuse, NY · New York, NY · +43 more sites
RecruitingPhase 1 / Phase 2NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Sponsor: Eikon Therapeutics
Lake Success, NY · New York, NY · +8 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
New York, NY · +21 more sites
RecruitingPhase 3NCT07548164
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +5 more sites
RecruitingPhase 2NCT04038502
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Sponsor: VA Office of Research and Development
New York, NY · The Bronx, NY · +16 more sites
RecruitingPhase 1NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Sponsor: SystImmune Inc.
New York, NY · +23 more sites
RecruitingPhase not listedNCT04995198
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Sponsor: Prostate Cancer Clinical Trials Consortium
New York, NY · +2 more sites
RecruitingPhase 3NCT06986083
A Study of Changes to Prostate Procedures
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +4 more sites
RecruitingPhase 2NCT06111781
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Sponsor: Yale University
New York, NY · +3 more sites
RecruitingNot applicableNCT00588185
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +4 more sites
RecruitingPhase 3NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Sponsor: Clarity Pharmaceuticals Ltd
Albany, NY · New York, NY · +27 more sites
RecruitingPhase 1NCT06458712
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Sponsor: Duke Street Bio Ltd
New York, NY · +3 more sites
RecruitingPhase 2NCT07111507
A Study of Tarlatamab for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +7 more sites
RecruitingPhase 1NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Sponsor: Nammi Therapeutics Inc
New York, NY · Rochester, NY · +8 more sites
RecruitingPhase not listedNCT07184970
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
Sponsor: NYU Langone Health
New York, NY
RecruitingPhase 1NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
New York, NY · +24 more sites
RecruitingPhase 2NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Sponsor: Prostate Cancer Clinical Trials Consortium
New York, NY · +7 more sites
RecruitingPhase 1 / Phase 2NCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Sponsor: Novartis Pharmaceuticals
Buffalo, NY · New York, NY · +19 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Bay Shore, NY · Forest Hills, NY · Lake Success, NY · +338 more sites
RecruitingPhase 2NCT07751159
Radiation Therapy Approaches for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +4 more sites
RecruitingPhase 1NCT06067841
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Sponsor: Bristol-Myers Squibb
New York, NY · +7 more sites
RecruitingPhase not listedNCT07184957
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
Sponsor: NYU Langone Health
New York, NY
RecruitingNot applicableNCT07225309
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 2NCT05751434
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Sponsor: City of Hope Medical Center
Commack, NY · Harrison, NY · New York, NY · +7 more sites
RecruitingPhase not listedNCT07203482
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
Sponsor: NYU Langone Health
Brooklyn, NY · New York, NY
RecruitingPhase 1NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
New York, NY · +10 more sites
RecruitingPhase 3NCT07052214
PSMA PET Combined With MRI for the Detection of PCa
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
New York, NY · +15 more sites
RecruitingPhase 3NCT06274047
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Sponsor: M.D. Anderson Cancer Center
New York, NY · +5 more sites
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
New York, NY · +21 more sites
RecruitingPhase 1NCT05413421
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Sponsor: ORIC Pharmaceuticals
New York, NY · +19 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.